PHARMA-STATS

1. Advanced Biostatistics

We use mixed models, advanced methods like Bayesian and estimand-based analysis. All methods follow ICH E9 and respective guidances. Every analysis is pre-specified in the SAP and coded in R.

advance-biostatistical
Innovative Clinical

2. Innovative Clinical Trial Design

We contribute to your protocol from the start. We define endpoints, estimands, and randomisation structure.
Our designs are built to pass regulatory review.

3. Sample Size Estimation

We calculate sample sizes for all endpoint types. We provide sensitivity analyses across key assumptions. All calculations come with reproducible R code.

Sample Size Estimation
Expert Statistical Programming

4. Expert Statistical Programming

We program all tables, listings, and figures in R. Every TLF is independently checked by a second statistician. We deliver programs, logs, and output documentation.

5. Adaptive Trials Design

We support sample size re-estimation and interim analyses.
We provide DSMB & Interim analysis support. All decision rules are pre-specified in the SAP.

6. Comprehensive Survival Analysis

At PHARMA-STATS, we provide statistical expertise in survival analysis with time-to-event endpoints using robust, reproducible, and regulatory-aligned methodologies, enabling confident clinical and regulatory decisions.

7. Oncology, Immunology & Rare Diseases

We provide statistical expertise across oncology, immunology, and rare disease studies, supporting complex clinical development programs and regulatory submissions.

Specialized Oncology Expertise
Pharmacokinetic and Bioequivalence Studies

8. Pharmacokinetic Studies

We perform NCA-based PK analysis and crossover BE analysis. We support reference-scaled average BE for highly variable drugs. 

9. Therapeutic Area Proficiency

We work across 18+ therapeutic areas. These include oncology, respiratory, cardiovascular, CNS, and rare diseases.
We also cover generic drug development and immunology.

Therapeutic Area Proficiency

10. Extensive Clinical Trials Experience

We have completed 200+ clinical and analytical projects. Our analyses have been submitted to FDA, EMA, MHRA, and DCGI. We have resolved 70+ regulatory queries with no unresolved objections.